0001104659-21-154397.txt : 20211229 0001104659-21-154397.hdr.sgml : 20211229 20211229213218 ACCESSION NUMBER: 0001104659-21-154397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211228 FILED AS OF DATE: 20211229 DATE AS OF CHANGE: 20211229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schroeder Theodore R CENTRAL INDEX KEY: 0001378690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 211530458 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2136401-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-28 0 0001641640 Nabriva Therapeutics plc NBRV 0001378690 Schroeder Theodore R 414 COMMERCE DR. SUITE 120 FORT WASHINGTON PA 19034 1 1 0 0 Chief Executive Officer Ordinary Shares 2021-12-28 4 P 0 100000 0.5732 A 325879 D The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5685 to $0.5750, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. /s/ Daniel Dolan, by power of attorney 2021-12-29